Geneva, October 11, 2021Updated on 10/11/2021 11:39 am
The Chinese vaccines developed by the Sinovac and Sinopharm laboratories, based on inactivated viruses, need to be administered in three doses, when until now two were inoculated, experts from the World Health Organization (WHO) who analyzed the global vaccination program.
LOOK: WHO recommends a third dose of coronavirus vaccine to risk groups
“All the evidence indicates that a third dose of these same vaccines or their counterparts is needed”said at a press conference the Mexican expert Alejandro Cravioto, president of the Strategic Advisory Group of Experts of the WHO (SAGE), referring to the Chinese sera.
SIGHT: The US confirms that it will allow the entry of those vaccinated with the doses approved by the WHO, including Sinopharm
The recommendation of the WHO may affect vaccination programs not only China, where most of the 2,200 million doses administered are from these two laboratories, but also countries in Latin America, Asia, Africa or Eastern Europe where these Chinese vaccines have been imported and used.
- Coronavirus: Argentina begins to vaccinate minors between 3 and 11 years old with Sinopharm
- Sinopharm and the other 5 vaccines that are valid to enter the United States
While Europe and the United States have not approved the use of the Sinovac and Sinopharm vaccines, the WHO has included them in its emergency use list and has asked the international community to do so to avoid discrimination at the entrance of travelers. from certain countries.
SIGHT: They claim that Russia stole AstraZeneca vaccine formula to develop Sputnik V against COVID-19
Cravioto indicated that these third doses should first be administered to people over 60 years of age, an age group that has shown greater problems of response to the coronavirus after being vaccinated with Sinovac O Sinopharm.
The SAGE expert, a group of experts that met last week to discuss global vaccination strategies, also opened the door for the third anticovid dose for people inoculated with Sinovac O Sinopharm It may be from one of the others approved by WHO (Pfizer, Moderna, Janssen, AstraZeneca).
According to the criteria of